RP
Riverbridge Partners’s Health Catalyst HCAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,222,571
| Closed | -$31.9M | – | 196 |
|
|
2022
Q1 | $31.9M | Buy |
1,222,571
+109,115
| +10% | +$2.85M | 0.36% | 81 |
|
|
2021
Q4 | $44.1M | Buy |
1,113,456
+40,825
| +4% | +$1.62M | 0.44% | 75 |
|
|
2021
Q3 | $53.6M | Sell |
1,072,631
-3,826
| -0.4% | -$191K | 0.54% | 68 |
|
|
2021
Q2 | $59.8M | Buy |
1,076,457
+51,747
| +5% | +$2.87M | 0.61% | 59 |
|
|
2021
Q1 | $47.9M | Sell |
1,024,710
-79,957
| -7% | -$3.74M | 0.55% | 60 |
|
|
2020
Q4 | $48.1M | Buy |
1,104,667
+118,965
| +12% | +$5.18M | 0.53% | 62 |
|
|
2020
Q3 | $36.1M | Buy |
+985,702
| New | +$36.1M | 0.5% | 66 |
|